Acyclovir Treatment for Pregnant Women with Chickenpox
Pregnant women with chickenpox should receive oral acyclovir if they present within 24 hours of rash onset, particularly those at risk for moderate to severe disease. 1
Indications for Acyclovir in Pregnancy
- Acyclovir is indicated for pregnant women at increased risk for moderate to severe varicella infection 1
- Risk factors that warrant acyclovir treatment include:
Dosing and Administration
- For oral treatment of uncomplicated varicella in pregnancy:
- For severe or complicated varicella (e.g., pneumonitis):
Safety in Pregnancy
- Acyclovir is classified as FDA Category B in pregnancy, indicating relative safety 1, 4, 5
- A registry of 596 infants exposed to acyclovir during first trimester showed no increased rate of birth defects compared to the general population 1, 5
- No pattern of adverse pregnancy outcomes has been reported after acyclovir exposure 6
Effectiveness
- Acyclovir reduces severity of symptoms and accelerates healing when started within 24 hours of rash onset 1, 2
- Five days of therapy is sufficient; longer courses provide no additional benefit 2
- Recent evidence suggests oral acyclovir may be as effective as varicella zoster immune globulin (VZIG) in preventing maternal chickenpox after exposure 7
Alternative Prevention Strategies
- For susceptible pregnant women exposed to varicella who have not yet developed symptoms:
Special Considerations
- For peripartum varicella (maternal rash 5 days before to 2 days after delivery):
- For pregnant women with varicella pneumonia: